» Articles » PMID: 26212494

The Key Regulator for Language and Speech Development, FOXP2, is a Novel Substrate for SUMOylation

Overview
Journal J Cell Biochem
Date 2015 Jul 28
PMID 26212494
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Transcription factor forkhead box protein P2 (FOXP2) plays an essential role in the development of language and speech. However, the transcriptional activity of FOXP2 regulated by the post-translational modifications remains unknown. Here, we demonstrated that FOXP2 is clearly defined as a SUMO target protein at the cellular levels as FOXP2 is covalently modified by both SUMO1 and SUMO3. Furthermore, SUMOylation of FOXP2 was significantly decreased by SENP2 (a specific SUMOylation protease). We further showed that FOXP2 is selectively SUMOylated in vivo on a phylogenetically conserved lysine 674 but the SUMOylation does not alter subcellular localization and stability of FOXP2. Interestingly, we observed that human etiological FOXP2 R553H mutation robustly reduces its SUMOylation potential as compared to wild-type FOXP2. In addition, the acidic residues downstream the core SUMO motif on FOXP2 are required for its full SUMOylation capacity. Finally, our functional analysis using reporter gene assays showed that SUMOylation may modulate transcriptional activity of FOXP2 in regulating downstream target genes (DISC1, SRPX2, and MiR200c). Altogether, we provide the first evidence that FOXP2 is a substrate for SUMOylation and SUMOylation of FOXP2 plays a functional role in regulating its transcriptional activity.

Citing Articles

Genetic variability of and its targets and in frontotemporal dementia: A pilot study in a southern Italian population.

Crocco P, De Rango F, Bruno F, Malvaso A, Maletta R, Bruni A Heliyon. 2024; 10(11):e31624.

PMID: 38828303 PMC: 11140708. DOI: 10.1016/j.heliyon.2024.e31624.


Molecular Organization and Regulation of the Mammalian Synapse by the Post-Translational Modification SUMOylation.

Chato-Astrain I, Pronot M, Coppola T, Martin S Cells. 2024; 13(5.

PMID: 38474384 PMC: 10930594. DOI: 10.3390/cells13050420.


FOXK2 transcription factor and its roles in tumorigenesis (Review).

Wang Z, Liu X, Wang Z, Hu Z Oncol Lett. 2022; 24(6):461.

PMID: 36380871 PMC: 9650603. DOI: 10.3892/ol.2022.13581.


A comprehensive in silico analysis of the deleterious nonsynonymous SNPs of human FOXP2 protein.

Akter M, Khan S, Sajib A, Rima F PLoS One. 2022; 17(8):e0272625.

PMID: 35944036 PMC: 9362936. DOI: 10.1371/journal.pone.0272625.


Molecular networks of the FOXP2 transcription factor in the brain.

den Hoed J, Devaraju K, Fisher S EMBO Rep. 2021; 22(8):e52803.

PMID: 34260143 PMC: 8339667. DOI: 10.15252/embr.202152803.


References
1.
Pichler A, Gast A, Seeler J, Dejean A, Melchior F . The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell. 2002; 108(1):109-20. DOI: 10.1016/s0092-8674(01)00633-x. View

2.
Martin S, Wilkinson K, Nishimune A, Henley J . Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat Rev Neurosci. 2007; 8(12):948-59. PMC: 3314512. DOI: 10.1038/nrn2276. View

3.
Lai C, Fisher S, Hurst J, Vargha-Khadem F, Monaco A . A forkhead-domain gene is mutated in a severe speech and language disorder. Nature. 2001; 413(6855):519-23. DOI: 10.1038/35097076. View

4.
Roll P, Vernes S, Bruneau N, Cillario J, Ponsole-Lenfant M, Massacrier A . Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex. Hum Mol Genet. 2010; 19(24):4848-60. PMC: 2989892. DOI: 10.1093/hmg/ddq415. View

5.
Schimmel J, Eifler K, Sigurdsson J, Cuijpers S, Hendriks I, Verlaan-de Vries M . Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein. Mol Cell. 2014; 53(6):1053-66. DOI: 10.1016/j.molcel.2014.02.001. View